Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, Research Institute for Health Sciences and Technology, University of Mons, Avenue du Champ de Mars, 8, 7000 Mons, Belgium.
Laboratory of Clinical and Experimental Oncology (LOCE), Institute Jules Bordet, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium.
Int J Mol Sci. 2023 Aug 15;24(16):12813. doi: 10.3390/ijms241612813.
Tumor-associated macrophages are key components of the tumor microenvironment and play important roles in the progression of head and neck cancer, leading to the development of effective strategies targeting immune cells in tumors. Our study demonstrated the prognostic potential of a new scoring system (Macroscore) based on the combination of the ratio and the sum of the high and low densities of M1 (CD80+) and M2 (CD163+) macrophages in a series of head and neck cancer patients, including a training population ( = 54) and a validation population ( = 19). Interestingly, the Macroscore outperformed TNM criteria and p16 status, showing a significant association with poor patient prognosis, and demonstrated significant predictive value for overall survival. Additionally, 3D coculture spheroids were established to analyze the crosstalk between cancer cells and monocytes/macrophages. Our data revealed that cancer cells can induce monocyte differentiation into protumoral M2 macrophages, creating an immunosuppressive microenvironment. This coculture also induced the production of immunosuppressive cytokines, such as IL10 and IL8, known to promote M2 polarization. Finally, we validated the ability of the macrophage subpopulations to induce apoptosis (M1) or support proliferation (M2) of cancer cells. Overall, our research highlights the potential of the Macroscore as a valuable prognostic biomarker to enhance the clinical management of patients and underscores the relevance of a spheroid model in gaining a better understanding of the mechanisms underlying cancer cell-macrophage interactions.
肿瘤相关巨噬细胞是肿瘤微环境的关键组成部分,在头颈部癌症的进展中发挥重要作用,导致针对肿瘤免疫细胞的有效策略的发展。我们的研究表明,基于一系列头颈部癌症患者中 M1(CD80+)和 M2(CD163+)巨噬细胞高、低密度比值和总和的新评分系统(Macroscore)具有预后潜力,包括训练人群(=54)和验证人群(=19)。有趣的是,Macroscore 优于 TNM 标准和 p16 状态,与患者预后不良显著相关,并显示出对总生存期的显著预测价值。此外,建立了 3D 共培养球体来分析癌细胞与单核细胞/巨噬细胞之间的串扰。我们的数据显示,癌细胞可以诱导单核细胞分化为促肿瘤的 M2 巨噬细胞,从而形成免疫抑制微环境。这种共培养还诱导产生了免疫抑制细胞因子,如已知促进 M2 极化的 IL10 和 IL8。最后,我们验证了巨噬细胞亚群诱导癌细胞凋亡(M1)或支持增殖(M2)的能力。总的来说,我们的研究强调了 Macroscore 作为有价值的预后生物标志物的潜力,以增强患者的临床管理,并强调了球体模型在更好地理解癌细胞-巨噬细胞相互作用的机制方面的相关性。